Sirona Medical Raises $40M in Series D Funding Led by Avidity Partners
Oct 16, 2026 | By Devin Jacobs
SUMMARY
- Sirona Medical raised $40 million in Series D funding.
- The funds will support AI development and expansion.
- Sirona Medical builds AI software for radiologists.
Sirona Medical, Inc., a San Francisco, CA-based provider of a cloud-native and AI-native radiology software platform (RadOS), has raised $40 million in a Series D funding round.
The round was led by Avidity Partners, with participation from 8VC, GreatPoint Ventures, KLT Holdings, and other new and existing investors.
The company will use the funding to expand its US implementation and 24/7 support teams, commercialise its agentic AI orchestration platform, Sirona Cortex, improve its Sirona Network tools, and expand into international markets.
What is Sirona Medical?
Sirona Medical develops RadOS, a cloud-native and AI-native software platform designed to bring radiology workflows into a single system.
Read More:AI Startup Forgepoint Raises $9.8M in Seed Funding
The platform combines diagnostic viewing, reporting, picture archiving and communication systems (PACS), worklists, and AI tools in one clinical workflow. It helps radiologists manage their work more efficiently and use AI within their existing processes.
Sirona also offers Sirona Network, which connects radiologists through shared cloud infrastructure. Its agentic AI orchestration layer, Sirona Cortex, is designed to coordinate AI capabilities across radiology workflows.
How Much Funding Has Sirona Medical Raised?
Sirona Medical has raised $40 million in its latest Series D funding round.
The source does not provide details of previous funding rounds or the company's total funding raised to date.
Who Invested in Sirona Medical’s Series D?
The $40 million Series D round was led by Avidity Partners.
Other participating investors include:
- 8VC
- GreatPoint Ventures
- KLT Holdings
- Other new and existing investors
Why the Funding Matters
Sirona Medical will use the funding to strengthen customer implementation and support in the United States, commercialise Sirona Cortex, and improve its Sirona Network tools.
The company also plans to launch Sirona Global to expand its operations into international markets, including the UK, European Union, South Africa, New Zealand, and Australia.
Who founded Sirona Medical?
Sirona Medical was founded in 2018 by Cameron Andrews. The company is headquartered in San Francisco, California.
"Sirona's mission has always been to accelerate the transition to AI-powered healthcare globally," said Cameron Andrews, Founder and President of Sirona Medical. "We pioneered a new category of software in 2018 to accomplish this, and thanks to the confidence of our customers, partners, and investors, Sirona now has the permanent capital necessary to deliver this vision to tens of millions of patients a year and at global scale."
"As the industry confronts a radiology staffing crisis, Sirona's customers are growing capacity faster than any other defined segment of the U.S. radiology market," said Ken Kaufman, Chief Executive Officer of Sirona Medical. "We're proud of the capacity we helped our customers build this year, and look forward to deploying RadOS to more practices, hospitals, health systems, and international markets in 2027."
Market and Business Growth
Sirona Medical has brought hundreds of radiologists onto its cloud-native infrastructure. More than half of its customers currently collaborate in some way through the RadOS platform.
Over 2027, the company plans to refine its Sirona Network tools with input from private practices and health system partners. The improvements are intended to help customers make better use of the shared platform.
Sirona also plans to publish a series called “Built on Sirona,” featuring customer stories and technical deep dives into RadOS and how radiology practices use the platform to address operational and economic challenges.
What Happens Next?
Sirona Medical plans to expand its US implementation and 24/7 support teams while bringing Sirona Cortex to market.
The company expects to launch Sirona Global before the end of 2026, extending its operational and commercial presence into the UK, EU, South Africa, New Zealand, Australia, and other international markets.
Read More:Fission Secures $10M in Series A Funding Led by Pantera Capital









